Financial Planning & Information Services, Inc. Abbott Laboratories Transaction History

Financial Planning & Information Services, Inc.

$725 Million
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$102.07 - $123.37 $184,134 - $222,559	-1,804 Closed	0 $0
Q1 2022 Apr 19, 2022	SELL	$114.02 - $139.04 $22,804 - $27,808	-200 Reduced 9.98%	1,804 $214,000
Q3 2021 Oct 13, 2021	BUY	$116.66 - $129.06 $5,483 - $6,065	47 Added 2.4%	2,004 $237,000
Q3 2020 May 24, 2021	BUY	$91.64 - $111.29 $179,339 - $217,794	1,957 New	1,957 $213,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.7 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.4 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.71 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.25 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Planning & Information Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Planning & Information Services, Inc. with notifications on news.

Account